LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA medicines for inherited retinal diseases (IRDs), today announced that Company management will participate in the following upcoming investor conferences:Citi’s 15th Annual BioPharma Virtual Conference
Thursday, September 10, 9:50-10:35 AM EST – Ophthalmology PanelH.C. Wainwright 22nd Annual Global Investment Conference
Tuesday, September 15, 1:30-1:50 PM EST – Fireside ChatCantor Virtual Global Healthcare Conference
Wednesday, September 16, 2:00-2:30 PM EST – Fireside ChatChardan Virtual 4th Annual Genetic Medicines Conference
Tuesday, October 6, 4:15-4:45 PM EST – Fireside ChatPresentation and webcast details can be found under ‘Events’ in the ‘Investors & Media’ section of the Company’s website (www.proqr.com). Archived webcasts will be available for approximately 30 days following the presentation date.About ProQR
Bay Street News